Developing evidence-based guidelines for describing potential benefits and harms within patient information leaflets/sheets (PILs) that inform and do not cause harm (PrinciPILs)
| dc.contributor.author | Howick, Jeremy | |
| dc.contributor.author | Svobodova, Martina | |
| dc.contributor.author | Treweek, Shaun | |
| dc.contributor.author | Gillies, Katie | |
| dc.contributor.author | Edwards, Adrian | |
| dc.contributor.author | Bower, Peter | |
| dc.contributor.author | Bostock, Jennifer | |
| dc.contributor.author | Jacob, Nina | |
| dc.contributor.author | Hood, Kerenza | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2025-09-09T09:40:01Z | |
| dc.date.issued | 2025-08-31 | |
| dc.description | We thank the advisory board for their guidance (Eleanor Mitchell, Senior Trial Manager, University of Nottingham; Ginette Hampshire, Senior Manager, Global Regulatory Strategy, Eisai Ltd; Imogen Goold, Associate Professor of Law, University of Oxford; Lauren Sutherland, QC, Ambersand Advocates; Jono Broad, Patient Experience Representative; Sheuli Porkess, Vice President, Faculty of Pharmaceutical Medicine; Fida Issa, Safety Surveillance Specialist, Novo Nordisk) | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 20 | |
| dc.format.extent | 1016974 | |
| dc.identifier | 308439047 | |
| dc.identifier | d1c0957f-45fa-4fdb-8dba-db7b9904ba9e | |
| dc.identifier | 105015092446 | |
| dc.identifier.citation | Howick, J, Svobodova, M, Treweek, S, Gillies, K, Edwards, A, Bower, P, Bostock, J, Jacob, N & Hood, K 2025, 'Developing evidence-based guidelines for describing potential benefits and harms within patient information leaflets/sheets (PILs) that inform and do not cause harm (PrinciPILs)', Health Technology Assessment, vol. 29, no. 43. https://doi.org/10.3310/GJJH2402 | en |
| dc.identifier.doi | 10.3310/GJJH2402 | |
| dc.identifier.iss | 43 | en |
| dc.identifier.issn | 1366-5278 | |
| dc.identifier.other | RIS: urn:1FEA225E6C2C77B9CFE3D34D9B06FB4D | |
| dc.identifier.other | ORCID: /0000-0001-7890-2854/work/190938303 | |
| dc.identifier.other | ORCID: /0000-0002-7239-7241/work/190938463 | |
| dc.identifier.uri | https://hdl.handle.net/2164/25956 | |
| dc.identifier.vol | 29 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Health Technology Assessment | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Supplementary Data | en |
| dc.subject | DAS | en |
| dc.subject.lcc | R1 | en |
| dc.title | Developing evidence-based guidelines for describing potential benefits and harms within patient information leaflets/sheets (PILs) that inform and do not cause harm (PrinciPILs) | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Howick_etal_HTA_Developing_Evidence_Based_VOR.pdf
- Size:
- 993.14 KB
- Format:
- Adobe Portable Document Format
